Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Tumor infiltrating lymphocytes (TIL) LN-145 for Breast Cancer
Recruiting1 awardPhase 2
This trial is testing a new treatment that uses a patient's own immune cells to fight metastatic Triple Negative Breast Cancer. It targets patients who have not responded well to previous treatments. The therapy aims to boost the body's natural defenses against cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service